It was an upbeat start to the session for the drinks maker AG Barr who issued a full year trading update this morning. Both revenues and margins ticked higher, with the combination delivering double digit profit growth. The company continues to invest both in plant and marketing, whilst recent acquisitions are also set to bolster the outlook, Shares in AG Barr added more than 7% in early trade.
The clinical stage biopharmaceutical company provided a market update this morning, advising of two key program updates. Management note that the development – including lifting maximum dosages - shows regulators are increasingly comfortable with the company’s tumour activated delivery platform. The Avacta share price added 7% in response to the news.
Precious metals prices continue to dominate the agenda for many, with gold powering back to the $5,000/oz level. Once again, that’s pushing the sector’s producer back into focus and in early trade, it’s Endeavour that is topping the FTSE-100 although peers are close behind. Expect the sector to remain volatile and sensitive to any geopolitical shock, but the Endeavour share price was up more than 6% shortly after the open.
Most read news on Investegate this morning
Faridoxorubicin Program Clinical Updates - - Avacta Group (AVCT)
